Skip to Main Content
Back to News

New Analyst Forecast: $IOBT Given 'Buy' Rating

None

We just received data on a new analyst forecast for $IOBT. H.C. Wainwright gave a rating of 'Buy' for $IOBT.

$IOBT Analyst Ratings

Wall Street analysts have issued reports on $IOBT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • H.C. Wainwright issued a "Buy" rating on 05/14/2025

To track analyst ratings and price targets for $IOBT, check out Quiver Quantitative's $IOBT forecast page.

$IOBT Insider Trading Activity

$IOBT insiders have traded $IOBT stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $IOBT stock by insiders over the last 6 months:

  • QASIM IFTIKHAR AHMAD (Chief Medical Officer) purchased 31,350 shares for an estimated $26,553
  • MAI-BRITT ZOCCA (Chief Executive Officer) purchased 12,500 shares for an estimated $10,120
  • DEVIN WHITTEMORE SMITH (General Counsel) purchased 12,000 shares for an estimated $9,720
  • AMY SULLIVAN (Chief Financial Officer) purchased 10,250 shares for an estimated $8,482

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$IOBT Hedge Fund Activity

We have seen 4 institutional investors add shares of $IOBT stock to their portfolio, and 17 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles